16-55823658-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001025195.2(CES1):c.431G>A(p.Gly144Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.01 in 151,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★).
Frequency
Genomes: 𝑓 0.010 ( 0 hom., cov: 39)
Exomes 𝑓: 0.012 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CES1
NM_001025195.2 missense
NM_001025195.2 missense
Scores
2
4
10
Clinical Significance
Conservation
PhyloP100: 0.892
Genes affected
CES1 (HGNC:1863): (carboxylesterase 1) This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This enzyme is the major liver enzyme and functions in liver drug clearance. Mutations of this gene cause carboxylesterase 1 deficiency. Three transcript variants encoding three different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.03447321).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CES1 | NM_001025195.2 | c.431G>A | p.Gly144Glu | missense_variant | 4/14 | ENST00000360526.8 | |
CES1 | NM_001025194.2 | c.428G>A | p.Gly143Glu | missense_variant | 4/14 | ||
CES1 | NM_001266.5 | c.428G>A | p.Gly143Glu | missense_variant | 4/14 | ||
CES1 | XM_005255774.3 | c.431G>A | p.Gly144Glu | missense_variant | 4/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CES1 | ENST00000360526.8 | c.431G>A | p.Gly144Glu | missense_variant | 4/14 | 1 | NM_001025195.2 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.0100 AC: 1519AN: 151544Hom.: 0 Cov.: 39
GnomAD3 genomes
?
AF:
AC:
1519
AN:
151544
Hom.:
Cov.:
39
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0109 AC: 2725AN: 249588Hom.: 0 AF XY: 0.0112 AC XY: 1505AN XY: 134858
GnomAD3 exomes
AF:
AC:
2725
AN:
249588
Hom.:
AF XY:
AC XY:
1505
AN XY:
134858
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0119 AC: 17324AN: 1450200Hom.: 0 Cov.: 35 AF XY: 0.0120 AC XY: 8645AN XY: 721462
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
17324
AN:
1450200
Hom.:
Cov.:
35
AF XY:
AC XY:
8645
AN XY:
721462
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0100 AC: 1519AN: 151662Hom.: 0 Cov.: 39 AF XY: 0.00930 AC XY: 690AN XY: 74154
GnomAD4 genome
?
AF:
AC:
1519
AN:
151662
Hom.:
Cov.:
39
AF XY:
AC XY:
690
AN XY:
74154
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
81
ExAC
?
AF:
AC:
1747
ClinVar
Significance: drug response
Submissions summary: Pathogenic:1Benign:1Other:2
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
not provided Pathogenic:1Benign:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | CES1: PM1, PS4:Moderate, PP4, PS3:Supporting - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 15, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
clopidogrel response - Efficacy Other:1
drug response, reviewed by expert panel | curation | PharmGKB | Mar 24, 2021 | PharmGKB Level of Evidence 2B: Variants in Level 2B clinical annotations are not in PharmGKB’s Tier 1 VIPs. These clinical annotations describe variant-drug combinations with a moderate level of evidence supporting the association. For example, the association may be found in multiple cohorts, but there may be a minority of studies that do not support the majority assertion. Level 2B clinical annotations must be supported by at least two independent publications. Drug-variant association: Efficacy |
clopidogrel response - Metabolism/PK Other:1
drug response, reviewed by expert panel | curation | PharmGKB | Mar 24, 2021 | PharmGKB Level of Evidence 2B: Variants in Level 2B clinical annotations are not in PharmGKB’s Tier 1 VIPs. These clinical annotations describe variant-drug combinations with a moderate level of evidence supporting the association. For example, the association may be found in multiple cohorts, but there may be a minority of studies that do not support the majority assertion. Level 2B clinical annotations must be supported by at least two independent publications. Drug-variant association: Metabolism/PK |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;.;D
Vest4
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at